amgen glp 1 Development Progress and Prospects of Antibody-Peptide Conjugates Generic of Novo's GLP-1 arrives
Description
JAMA Intern Med 2024;184:14452
Ive never felt saferor more supportedon a weight loss journey
While this is certainly a reasonable concern, we view the FDAs decision on Bydureon as excessive, given the lack of any signal for a cardiovascular safety issue and the amount of data already submitted
Additionally, Ozempic, Wegovy, Mounjaro and Zepbound will be available at $245 for patients on Medicare with a copay of $50 per month as soon as April 1, 2026
Aspirin is inexpensive, widely available, and supported by randomized evidence, but its bleeding risk limits universal use
